Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000

K-Number: K131085 · 2013-08-22

ApplicantMespere Lifesciences, Inc.
Decision Date2013-08-22
Product CodePFA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000 is the device name listed in this FDA 510(k) record. The listed applicant is Mespere Lifesciences, Inc.. It received FDA 510(k) clearance on 2013-08-22 under 510(k) number K131085. The device is classified under product code PFA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000?

CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000 is a medical device that received FDA 510(k) clearance on 2013-08-22. The listed applicant is Mespere Lifesciences, Inc.. The 510(k) number is K131085.

When did CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000 receive FDA 510(k) clearance?

CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000 received FDA 510(k) clearance on 2013-08-22, under 510(k) number K131085.

Who is the listed applicant for CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000?

The FDA 510(k) record lists Mespere Lifesciences, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000?

The FDA product code for CENTRAL VENOUS PRESSURE SYSTEM - MESPERE VENUS 1000 is PFA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Mespere Lifesciences, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K182242VO200 – NeurOs Cerebral Oximetry System

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑